RxSight, Inc. (RXST) Tops Q3 EPS by 34c, provides guidance

RxSight, Inc. (NASDAQ: RXST) reported Q3 EPS of ($0.04), $0.34 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $30.3 million versus the consensus estimate of $25.28 million.

GUIDANCE:

RxSight, Inc. sees FY2025 revenue of $125-130 million, versus the consensus of $125.9 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• C3 AI (AI) call put ratio 1.6 calls to 1 put into quarter results
• Gold.com (GOLD) call put ratio 2.4 calls to 1 put into quarter results